Abstract:Abstract Introduction Hematopoietic stem cells (HSCs) sustain lifelong blood production and can be used in allogenic stem cell transplantation for treatment of hematological malignancies, yet the mechanisms of their DNA damage response (DDR) remain largely unexplored. Genotoxic damage can be induced by chemotherapeutical agents (eg, etoposide, a topoisomerase II inhibitor) or by methylating agents (eg, nitrosamines). Related double strand breaks (DSBs) at the level of immature cells are thus presumed to trigger leukemia. Objective Human quiescent and cycling HSCs were reported to exhibit distinct responses to genotoxic stress upon in vitro exposure to sublethal doses of etoposide or N-nitroso-N-methylurea (MNU). In this context, we aim to identify and compare the mechanisms involved in the determination of HSC stem and progenitor cell fate upon DNA damage to gain more insights into cytotoxic anticancer drug- and contaminant-related hematological toxicity. Methods Quiescent human HSCs (CD34+) were isolated from umbilical cord blood, sorted and directly exposed to etoposide or MNU. Besides, CD34+ were expanded in-vitro in medium containing broad acting cytokines for 5 days prior genotoxic exposure. Sublethal doses were assessed by Alamar Blue assay. Propidium iodide staining and colony-forming unit assay (CFU) were used for cell cycle analysis and tracking of cell functionality. Results In vitro inhibitory concentrations were identified for human HSCs treated with etoposide (IC50 = 5 μM) and MNU (IC50 = 1 mM). Treatment of quiescent HSCs with lower genotoxin concentrations induces a cell cycle arrest in the G0/G1-phase, whereas higher concentrations activate apoptosis-related genes and completely abrogate further differentiation into colony-forming progenitors. In contrast, cycling HSCs exhibit an impaired proliferation, upregulation of autophagy-related genes, reduced proportions of viable CD34+ cells, and similar effects regarding differentiation capacity into colony-forming progenitors. However, cells exposed to lower genotoxin doses exhibit a higher regeneration capacity 3 days upon treatment. Discussion These results confirm that the DDR following DSB-induction differs between quiescent and cycling HSCs. Quiescent HSCs exhibit a stronger DDR, probably related to their longer lifespan. To avoid malignant transformation, it is necessary to preclude damage accumulation through cell cycle withdrawal and apoptosis. In contrast, more committed cells rather inline toward damage repair and restoration through activation of, for example, non-homologous end joining or mismatch repair genes.

DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells.

DNA Damage and Repair in the Hematopoietic System

Abstract 1 Distinctive and Differentiation-State Dependent DNA Damage Response of Hematopoietic Stem Cells to Genotoxic Noxae

Crosstalk between DNA Damage Repair and Metabolic Regulation in Hematopoietic Stem Cells

DNA Damage Response in Hematopoietic Stem Cell Ageing

The DNA damage and regulatory strategy in hematopoietic stem cells after irradiation exposure: Progress and challenges

DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies

Leukemia Stem Cells: the Root of Chronic Myeloid Leukemia

The regulation of hematopoietic stem cell fate in the context of radiation

Targeting the DNA damage response in hematological malignancies

The Roles of DNA Damage Response Machineries in Maintaining Genome Stability&Cellular Homeo-stasis

Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma

DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance

HMCES Safeguards Genome Integrity and Long-Term Self-Renewal of Hematopoietic Stem Cells During Stress Responses.

Molecular Regulation of Hematopoietic Stem Cell Quiescence

Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cells

DNA damage response after treatment of cycling and quiescent cord blood hematopoietic stem cells with distinct genotoxic noxae

The role of DNA repair in the pluripotency and differentiation of human stem cells

Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance

Characterizing the Dna Damage Response in Putative Stem Cells of Resected Normal Lung and Matched Nsclc Patient Samples

The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy